All News
Motivating presentation on how to bring the future to the present, by Prof. McInnes.
Identifying clusters of patients with PsA using Machine Learning. First step to achieve a personalized treatment for every patient #EULAR2019 https://t.co/5xRECw0gG5
Diego Benavent Núñez DiegoBenavent ( View Tweet)
In a large Danish study of #RA patients, those on #biologics and those on conventional #DMARDs had the same incidence of #jointreplacement #EULAR2019 https://t.co/ZgdkVZ8sYa
CreakyJoints.org CreakyJoints ( View Tweet)
Ross Wilkie and his team found walking frequency, depression and insomnia are #mediators of #osteoarthritis effects on #mortality. https://t.co/sXhff6moFd
OACOP KeeleOACOP ( View Tweet)
What happens to the #muscles in patients with Giant Cell Arteritis after prolonged #steroid treatment?🤔
Find out at #EULAR2019 poster THU0605
Dr Alfuraih will explain using #ultrasound #shearwave #elastography
#muscle #imaging https://t.co/VrzfdNiE3I
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
#Lupus associated genetic variants contribute to organ damage #EULAR2019 https://t.co/644BudBQyp
Juan Ovalles, MD, PhD DrJuanOvalles ( View Tweet)
Thomas Dorner tells us not to lose hope in lupus trials, and that they are just following what is called the Kuhn cycle! https://t.co/xeaaUwfwgp #EULAR2019
Alberta Hoi tuna0sashimi ( View Tweet)
Genentech presenta nuevos datos sobre un nuevo tratamiento para el Lupus con afectación renal. Obinituzumab, Nueva esperanza para pacientes con nefritis lúpica! #EULAR2019 https://t.co/Jjl5zTBKGN
Jose María Alvaro Gracia AlvaroGraciaSER ( View Tweet)
Dr Ross Wilkie won one of the Best Abstract Awards at the European Congress of Rheumatology #EULAR2019. His study identified targets for reducing premature death in older people with #osteoarthritis. Great research led by health professionals. #HPR https://t.co/RZ2salIn3M https://t.co/huAilBKUCG
Links:
Mwidimi Ndosi ndosie ( View Tweet)
Co-founder and Director of dotMD Dr Ronan Kavanagh explains what was involved in choosing speakers for this year’s conference https://t.co/FFiqxje4HF @DotMDConf @RonanTKavanagh
Links:
Medical Independent med_indonews ( View Tweet)
Minimal Disease Activity in PsA is more challenging in women than in men. Unpublished data from the TICOPA trial presented by Dr. Laura Coates. #PsA #EULAR2019
Xabier Michelena Vegas xabiermich ( View Tweet)
What factors are linked with fatigue in women in the first year of #RA? One #EULAR2019 study found these 4: obesity, steroid use, seronegativity, and poor sleep https://t.co/40lyEXjE2U
CreakyJoints.org CreakyJoints ( View Tweet)
New anti-CD20 Mab Obinutuzumab just delivered positive results in its phase 2 study in lupus nephritis. We need to know more! #EULAR2019 https://t.co/Bx9OdmEtpy
Alberta Hoi tuna0sashimi ( View Tweet)
Hydroxychloroquine: proposed risk factors for Retinopathy #EULAR2019 https://t.co/WkyNZ4GPVr
Dr Irwin Lim _connectedcare ( View Tweet)
Mease: SEAM study MTX vs Etanercept in PsA.
ETA effects > MTX with no additional benefit of combination.
But some MTX benefit (note no PBO arm).
Interesting separation between MTX<ETA for PASDAS (muli domain) but not DAPSA (joints only) #Eular2019 @RheumNow https://t.co/WSUlGE7NEf
Stefan Siebert StefanSiebert1 ( View Tweet)
#Gout patients tend not to tell doctors impact of gout on quality of life
👉🏼43% #mentalhealth
👉🏼27% impact on family
👉🏼26% relationship with partners
➡️🔟% lost job or retired due to gout
by Meulemeester #EULAR2019 https://t.co/fyrAyvpaYO
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
Mease: Filgotinib (selective JAK1i) in active PsA ph2. Promising data.
Interesting and informative way to present individual participant level data over time rather than just aggregate data - may be more useful for clinicians and patients to understand.
#EULAR2019 @RheumNow https://t.co/B0pLODWGJ9
Stefan Siebert StefanSiebert1 ( View Tweet)
So, what are we left with? Some patients get another year free of remission - that’s good. TCZ is steroid-sparing - that’s good. Still questions about longer follow-up and sequelae, and a year’s therapy doesn’t cure everyone. It’s not a panacea for all GCA ills, but it’s a start! https://t.co/6AiIQLnLFN
David Liew drdavidliew ( View Tweet)
Well it’s not all she wrote when flares come along, flares can be treated - some data on how to fix them, but beware the channeling bias https://t.co/o0rwYr1Ll7
David Liew drdavidliew ( View Tweet)
McInnes: Machine-learning separates out 13 clusters of PsA in RCT population (i.e. already selected).
Offers opportunities to reduce some of the massive heterogeneity in PsA to help inform biomarker studies and future precision medicine strategies. #Eular2019 @RheumNow https://t.co/h3Otp4Oq8U
Stefan Siebert StefanSiebert1 ( View Tweet)
For new knee inflammatory arthritis nearly 60% are in full remission at one year whereas 10% spread to progressive arthritis and 30% have persistent knee IA. Leiden Early arthritis cohort #EULAR2019 @RheumNow https://t.co/ZuLI1OCfhT https://t.co/x2Tr1tF0j6
Janet Pope Janetbirdope ( View Tweet)